Stock listing
Xetra:AVG Avantor, Inc. Aktie
German listing (Xetra) of Avantor, Inc. · home listing NYSE:AVTR
Follow Avantor, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:AVTR
$14.84 USD -0.53 (-3.4%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:AVTR
- Day range
- $14.80 – $15.50 USDNov 20, 2026
- Volume
- 12.25M sharesNov 20, 2026
- Market cap
- $10.06B USDAt the close on Nov 20, 2026 · price × 677.6M shares outstanding
- 52-week range
- $7.27 – $17.45 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $136.3M USDMedian day 7.85M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:AVTR · Home | $14.84 USD | -0.53 (-3.4%) | 12,253,271 | $15.11 | $15.50 | $14.80 | $15.37 | Close on Nov 20, 2026 |
| Frankfurt:AVG | €13.87 EUR | -0.115 (-0.8%) | — | €13.87 | €13.87 | €13.87 | €13.98 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:AVTR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $14.84 | -0.53 | -3.4% | $15.11 | $15.50 | $14.80 | 12,253,271 | |
| $15.37 | +0.19 | +1.3% | $15.08 | $15.45 | $15.08 | 5,940,236 | |
| $15.18 | -0.14 | -0.9% | $15.37 | $15.46 | $15.11 | 5,932,077 | |
| $15.32 | -0.22 | -1.4% | $15.46 | $15.62 | $15.27 | 6,146,345 | |
| $15.54 | -0.08 | -0.5% | $15.63 | $15.70 | $15.44 | 6,819,433 | |
| $15.62 | -0.11 | -0.7% | $15.47 | $15.99 | $15.25 | 3,643,985 | |
| $15.73 | +0.16 | +1.0% | $15.76 | $15.90 | $15.59 | 5,536,821 | |
| $15.57 | -0.34 | -2.1% | $15.81 | $15.88 | $15.49 | 6,345,791 | |
| $15.91 | +0.44 | +2.8% | $15.59 | $15.95 | $15.35 | 8,124,364 | |
| $15.47 | +0.33 | +2.2% | $15.07 | $15.60 | $15.07 | 6,142,985 | |
| $15.14 | -0.51 | -3.3% | $15.60 | $15.67 | $15.09 | 7,463,697 | |
| $15.65 | +0.06 | +0.4% | $15.88 | $16.19 | $15.45 | 10,046,375 | |
| $15.59 | -0.02 | -0.1% | $15.67 | $16.01 | $15.57 | 8,756,775 | |
| $15.61 | -0.44 | -2.7% | $16.09 | $16.09 | $15.56 | 9,404,169 | |
| $16.05 | -0.63 | -3.8% | $16.74 | $16.74 | $15.85 | 9,733,762 | |
| $16.68 | -0.01 | -0.1% | $16.65 | $16.73 | $16.34 | 11,217,828 | |
| $16.69 | -0.44 | -2.6% | $16.41 | $17.22 | $16.17 | 29,719,213 | |
| $17.13 | -0.16 | -0.9% | $17.29 | $17.39 | $17.07 | 10,688,592 | |
| $17.29 | 0.00 | 0.0% | $17.14 | $17.38 | $17.14 | 6,732,733 | |
| $17.29 | +0.14 | +0.8% | $17.10 | $17.32 | $16.90 | 7,871,097 | |
| $17.15 | -0.11 | -0.6% | $17.29 | $17.45 | $16.97 | 12,740,517 | |
| $17.26 | +0.64 | +3.9% | $16.45 | $17.33 | $16.45 | 11,634,088 | |
| $16.62 | +0.33 | +2.0% | $16.38 | $16.83 | $16.24 | 9,148,366 | |
| $16.29 | -0.13 | -0.8% | $16.42 | $16.55 | $16.19 | 9,314,074 | |
| $16.42 | +0.33 | +2.1% | $16.10 | $16.45 | $15.95 | 29,356,100 | |
| $16.09 | +0.39 | +2.5% | $15.83 | $16.26 | $15.70 | 5,968,900 | |
| $15.70 | +0.15 | +1.0% | $15.61 | $16.00 | $15.61 | 8,051,700 | |
| $15.55 | +0.06 | +0.4% | $15.53 | $15.66 | $15.44 | 4,645,900 | |
| $15.49 | -0.18 | -1.1% | $15.71 | $15.76 | $15.39 | 5,918,800 | |
| $15.67 | +0.28 | +1.8% | $15.45 | $15.76 | $15.42 | 4,244,100 | |
| $15.39 | +0.04 | +0.3% | $15.22 | $15.42 | $14.96 | 12,125,800 | |
| $15.35 | -0.08 | -0.5% | $15.38 | $15.52 | $15.04 | 6,007,500 | |
| $15.43 | -0.38 | -2.4% | $15.95 | $16.38 | $15.42 | 11,387,700 | |
| $15.81 | +0.47 | +3.1% | $15.34 | $15.87 | $15.24 | 8,180,400 | |
| $15.34 | +0.31 | +2.1% | $15.11 | $15.38 | $14.97 | 6,149,100 | |
| $15.03 | -0.02 | -0.1% | $14.94 | $15.20 | $14.57 | 10,567,400 | |
| $15.05 | -0.19 | -1.2% | $15.16 | $15.36 | $15.05 | 7,378,800 | |
| $15.24 | -0.05 | -0.3% | $15.18 | $15.42 | $15.06 | 6,911,500 | |
| $15.29 | +0.04 | +0.3% | $15.10 | $15.41 | $15.07 | 9,436,700 | |
| $15.25 | -0.13 | -0.8% | $15.33 | $15.36 | $15.08 | 6,529,500 | |
| $15.38 | +0.62 | +4.2% | $14.72 | $15.43 | $14.67 | 7,719,600 | |
| $14.76 | -0.18 | -1.2% | $14.95 | $15.14 | $14.72 | 10,569,300 | |
| $14.94 | -0.16 | -1.1% | $15.13 | $15.32 | $14.91 | 11,164,200 | |
| $15.10 | -0.42 | -2.7% | $15.39 | $15.59 | $15.04 | 9,194,200 | |
| $15.52 | -0.34 | -2.1% | $15.87 | $15.90 | $15.44 | 14,825,100 | |
| $15.86 | +0.25 | +1.6% | $15.81 | $16.05 | $15.64 | 9,832,700 | |
| $15.61 | +0.17 | +1.1% | $15.53 | $15.82 | $15.42 | 10,554,300 | |
| $15.44 | +0.28 | +1.8% | $15.22 | $15.65 | $15.19 | 8,185,300 | |
| $15.16 | +0.35 | +2.4% | $14.87 | $15.17 | $14.70 | 9,136,100 | |
| $14.81 | -0.07 | -0.5% | $15.01 | $15.05 | $14.70 | 6,179,000 | |
| $14.88 | 0.00 | 0.0% | $14.72 | $14.94 | $14.60 | 7,537,900 | |
| $14.88 | -0.37 | -2.4% | $15.08 | $15.16 | $14.72 | 7,845,600 | |
| $15.25 | +0.28 | +1.9% | $14.83 | $15.46 | $14.67 | 12,503,700 | |
| $14.97 | -0.22 | -1.4% | $15.13 | $15.18 | $14.85 | 7,654,000 | |
| $15.19 | +0.54 | +3.7% | $14.78 | $15.20 | $14.59 | 9,319,100 | |
| $14.65 | +0.45 | +3.2% | $14.22 | $14.84 | $14.22 | 8,921,300 | |
| $14.20 | -0.34 | -2.3% | $14.55 | $14.63 | $14.19 | 5,670,200 | |
| $14.54 | -0.04 | -0.3% | $14.54 | $14.59 | $14.34 | 6,535,600 | |
| $14.58 | -0.03 | -0.2% | $14.50 | $14.65 | $14.45 | 5,301,600 | |
| $14.61 | +0.11 | +0.8% | $14.51 | $14.70 | $14.43 | 5,997,284 | |
| $14.50 | +0.08 | +0.6% | $14.23 | $14.63 | $14.20 | 4,772,300 | |
| $14.42 | +0.16 | +1.1% | $14.26 | $14.50 | $14.05 | 5,555,185 | |
| $14.26 | -0.20 | -1.4% | $14.29 | $14.36 | $14.05 | 5,192,724 | |
| $14.46 | +0.21 | +1.5% | $14.31 | $14.49 | $14.16 | 6,063,700 | |
| $14.25 | +0.29 | +2.1% | $13.79 | $14.48 | $13.76 | 7,130,600 |
- Ticker
- Xetra:AVG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
Avantor® Reports Third Quarter 2026 Results
Latest earnings call · Oct 28, 2026
Avantor (NYSE:AVTR) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 28, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Latest news
Avantor® Reports Third Quarter 2026 Results
Oct 28, 2026
Closed $16.69 (-2.6%) on Oct 28, 2026
Avantor appoints new Chief Information Officer
Oct 26, 2026
Closed $17.29 (0.0%) on Oct 26, 2026
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
Oct 1, 2026
Closed $15.03 (-0.1%) on Oct 1, 2026
Avantor appoints new Chief Financial Officer
Sep 21, 2026
Closed $15.10 (-2.7%) on Sep 21, 2026
Avantor® Reports Second Quarter 2026 Results
Jul 29, 2026
Closed $14.38 (+15.8%) on Jul 29, 2026
Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product
Jul 14, 2026
Closed $11.29 (+6.9%) on Jul 14, 2026
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
Jul 8, 2026
Closed $9.76 (-4.3%) on Jul 8, 2026
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
May 19, 2026
Closed $7.64 (+0.5%) on May 19, 2026
Avantor® Reports First Quarter 2026 Results
Apr 29, 2026
Closed $7.85 (-0.1%) on Apr 29, 2026
Avantor, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 25 in the last 12 months · 46 in all · newest Oct 28, 2026 · oldest 2025
- Calls
- 28 calls with a replay · 28 with a transcript · latest Oct 28, 2026
- Decks
- 7 decks · latest Oct 28, 2026
Where Avantor, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:AVTR · Home listing | NYSE | United States | USD |
| Frankfurt:AVG | Frankfurt | Germany | EUR |
| gettex:AVG | gettex | Germany | EUR |
| LS Exchange:A2PJN6 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PJN6 | Lang & Schwarz | Germany | EUR |
| BMV:AVTR | BMV | Mexico | MXN |
| Tradegate:AVG | Tradegate | Germany | EUR |
| Munich:AVG | Munich | Germany | EUR |
| VIE:AVTR | Vienna | Austria | EUR |
| BIVA:AVTR | BIVA | Mexico | MXN |
| BOATS:AVTR | BOATS | United States | USD |
| Dusseldorf:AVG | Dusseldorf | Germany | EUR |
| Stuttgart:AVG | Stuttgart | Germany | EUR |
| Xetra:AVG · This page | Xetra | Germany | EUR |
Valuation
P/E 29.8× against a median of 27.8×: 5th lowest of 8 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $13.28B USD
- P/E
- 29.8×
- EV/sales
- 2.0×
- EV/EBITDA
- 14.7×
- Price/book
- 1.7×
- Gross margin
- 31.6%
- Operating margin
- 7.3%
- Net margin
- 5.1%
- Debt to equity
- 0.6×
- Beta vs S&P 500
- 0.78
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Avantor, Inc. · NYSE:AVTR | US$10.06B | US$13.28B | 29.8× | 2.0× | 14.7× | 1.7× | 5.1% | 0.6× | 0.78 |
| bioMerieux SA · EURONEXT:BIM | US$11.79B | US$11.53B | 27.0× | 2.6× | 10.9× | 2.5× | 9.8% | 0.1× | n/a |
| Bio-Techne Corp · NASDAQ:TECH | US$11.41B | US$11.35B | 66.4× | 9.2× | 33.6× | 5.3× | 14.0% | 0.1× | 0.54 |
| Qiagen N.V. · NYSE:QGEN | US$10.18B | US$11.03B | 24.9× | 5.3× | 15.0× | 3.0× | 19.5% | 0.5× | 0.33 |
| WuXi XDC Cayman, Inc. · HKEX:2268 | US$9.64B | US$8.87B | 43.5× | 10.0× | 33.5× | 5.7× | 24.9% | 0.1× | n/a |
| Tempus AI, Inc. · NASDAQ:TEM | US$9.58B | US$8.99B | n/a | 6.0× | n/a | 19.1× | −12.5% | 0.0× | 2.51 |
| Bruker Corporation · NASDAQ:BRKR | US$8.62B | US$10.22B | n/a | 2.9× | 64.4× | 3.7× | −3.5% | 0.7× | 1.72 |
| Pharmaron Beijing Co., Ltd. Class A · SZSE:300759 | US$8.52B | US$8.23B | 32.1× | 3.4× | n/a | 3.4× | 11.1% | 0.1× | n/a |
| GenScript Biotech Corporation · HKEX:1548 | US$8.08B | US$7.50B | n/a | 7.8× | 22.8× | 2.1× | −55.5% | 0.1× | n/a |
| Bio-Rad Laboratories, Inc. · NYSE:BIO | US$7.84B | US$7.38B | 7.7× | 2.8× | 71.0× | 1.0× | 39.5% | 0.2× | 0.72 |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832 | US$7.51B | US$7.10B | 27.8× | 9.8× | n/a | 5.3× | 37.2% | 0.0× | n/a |
| Median of the others | US$9.10B | US$8.93B | 27.8× | 5.6× | 33.5× | 3.6× | 12.5% | 0.1× | 0.72 |
Forecasts
2 strong buy · 12 hold · 1 sell · Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 17.35 USD · Analysts' mean
- EPS, year to Dec 2026
- 0.82 · 15 analysts
- Revenue, year to Dec 2026
- 6.67B · 14 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Todd Garner | Executive Vice President and Chief Financial Officer |
| Mary Blenn | Executive Vice President and Chief Operating Officer |
| Allison Hosak | Investor Relations |
| Chris Fidyk | Investor Relations |
| Swati Chhabra | Manager, Corporate Communications |
| Gladys Wang | Vice President, Bioprocessing Commercial, Asia, Middle East & Africa |
| Ludovic Brellier | Executive Vice President, Bioscience & Medtech Products |
| Mikey Santiago | Chief Information Officer |
Board
| Director | Role |
|---|---|
| Gregory T. Lucier | Director |
| Sanjeev Mehra | Director |
| Simon Dingemans | Director |
Events
- Next results
- Feb 10, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Avantor (NYSE:AVTR) Q3 2026 Earnings Call | Wed, Oct 28, 2026 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q2 2026 Earnings Call | Wed, Jul 29, 2026 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q1 2026 Earnings Call | Wed, Apr 29, 2026 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q4 2025 Earnings Call | Wed, Feb 11, 2026 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q3 2025 Earnings Call | Wed, Oct 29, 2025 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q2 2025 Earnings Call | Fri, Aug 01, 2025 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q1 2025 Earnings Call | Fri, Apr 25, 2025 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q4 2024 Earnings Call | Fri, Feb 07, 2025 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q3 2024 Earnings Call | Fri, Oct 25, 2024 · 8:00 AM ET | Replay |
| Avantor (NYSE:AVTR) Q2 2024 Earnings Call | Fri, Jul 26, 2024 · 8:00 AM ET | Replay |
All 28 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 28, 2026 · Before open | −2.6% |
| Q2 2026 | Jul 29, 2026 · Before open | +15.8% |
| Q1 2026 | Apr 29, 2026 · Before open | −0.1% |
| Q4 2025 | Feb 11, 2026 · Before open | −13.6% |
| Q3 2025 | Oct 29, 2025 · Before open | −23.2% |
| Q2 2025 | Aug 1, 2025 · Before open | −15.5% |
| Q1 2025 | Apr 25, 2025 · Before open | −16.6% |
| Q4 2024 | Feb 7, 2025 · Before open | −11.7% |
| Q3 2024 | Oct 25, 2024 · Before open | −3.6% |
| Q2 2024 | Jul 26, 2024 · Before open | +12.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 26, 2024 · Before open | −4.8% |
| Q4 2023 | Feb 14, 2024 · Before open | +10.2% |
| Q3 2023 | Oct 27, 2023 · Before open | −8.7% |
| Q2 2023 | Jul 28, 2023 · Before open | −6.8% |
| Q1 2023 | Apr 28, 2023 · Before open | +4.0% |
| Q4 2022 | Feb 3, 2023 · Before open | −7.4% |
| Q3 2022 | Oct 28, 2022 · Before open | −6.4% |
| Q2 2022 | Jul 28, 2022 · After close | −10.2% |
| Q1 2022 | Apr 28, 2022 · After close | +7.0% |
| Q4 2021 | Feb 3, 2022 · After close | −1.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 15 slides | Oct 28, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 15 slides | Jul 29, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 10 slides | Apr 29, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 16 slides | Feb 11, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 11 slides | Oct 29, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 9 slides | Aug 1, 2025 |
| Conference Presentation (October 2022) | Conference | 13 slides | October 2022 |
IPO
Priced at US$14.00 a share on May 16, 2019.
- Price
- US$14.00 a share
- Shares offered
- 207,000,000 shares of common stock
- Offering size
- US$2.9 billion
- Underwriters' option
- Up to 2,700,000 more shares
- Underwriters
- Goldman Sachs & Co. LLC, J.P. Morgan, BofA Merrill Lynch, Barclays, Jefferies, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners LP, Raymond James, Stephens Inc., Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities, Drexel Hamilton · In the order on the cover
- Shares delivered
- On or about May 21, 2019
Steps
| Step | When |
|---|---|
| Filed publicly | Feb 8, 2019 |
| Amended 8 times | Newest May 16, 2019 |
| Shares registered with an exchange | May 13, 2019 |
| Declared effective by the SEC | May 16, 2019 |
| Final prospectus, with the price | May 20, 2019 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | May 20, 2019 |
| 424B4 · Prospectus | May 20, 2019 |
| FWP · Free writing prospectus | May 17, 2019 |
| EFFECT · Notice that a registration is effective | May 16, 2019 |
| S-1MEF · Registration of more shares for the same offering | May 16, 2019 |
| S-1/A · Registration statement, amended | May 16, 2019 |
| S-1/A · Registration statement, amended | May 16, 2019 |
| FWP · Free writing prospectus | May 16, 2019 |
| CORRESP · Letter to the SEC | May 14, 2019 |
| CORRESP · Letter to the SEC | May 14, 2019 |
All 28 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | May 14, 2019 |
| CERT · Exchange's certificate of listing | May 14, 2019 |
| 8-A12B · Registration of shares for listing on an exchange | May 13, 2019 |
| CORRESP · Letter to the SEC | May 7, 2019 |
| UPLOAD · Letter from the SEC | May 6, 2019 |
| CORRESP · Letter to the SEC | May 3, 2019 |
| S-1/A · Registration statement, amended | May 3, 2019 |
| S-1/A · Registration statement, amended | Apr 30, 2019 |
| S-1/A · Registration statement, amended | Apr 25, 2019 |
| CORRESP · Letter to the SEC | Apr 25, 2019 |
| UPLOAD · Letter from the SEC | Apr 24, 2019 |
| S-1/A · Registration statement, amended | Apr 10, 2019 |
| CORRESP · Letter to the SEC | Apr 5, 2019 |
| S-1/A · Registration statement, amended | Apr 5, 2019 |
| UPLOAD · Letter from the SEC | Mar 29, 2019 |
| S-1/A · Registration statement, amended | Mar 15, 2019 |
| UPLOAD · Letter from the SEC | Mar 7, 2019 |
| S-1 · Registration statement | Feb 8, 2019 |
Open IPO · From the cover of the final prospectus (424B4) filed May 20, 2019
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.55B | 6.78B | 6.97B | 7.51B | 7.39B | 6.39B | 6.04B | 5.86B | 1.25B |
| Cost of revenue | 4.41B | 4.50B | 4.60B | 4.91B | 4.88B | 4.31B | 4.12B | 4.04B | 814.6M |
| Gross profit | 2.14B | 2.28B | 2.36B | 2.60B | 2.50B | 2.08B | 1.92B | 1.82B | 432.8M |
| Selling, general and administrative | 1.60B | 1.64B | 1.51B | 1.47B | 1.53B | 1.37B | 1.37B | 1.41B | 449.7M |
| Operating income | -246.2M | 1.08B | 696.4M | 1.13B | 972.2M | 706.8M | 551.8M | 413.5M | -210.4M |
| Depreciation and amortization | 410.2M | 405.5M | 402.3M | 405.5M | 379.2M | 395.4M | 398.9M | 404.6M | 99.2M |
| EBITDA | 164.0M | 1.49B | 1.10B | 1.54B | 1.35B | 1.10B | 950.7M | 818.1M | -111.2M |
| Interest expense | 169.8M | 218.8M | 284.8M | 265.8M | 217.4M | 307.6M | 440.0M | 523.8M | 200.9M |
| Income before tax | -441.3M | 853.9M | 410.5M | 851.1M | 753.0M | 62.3M | 40.6M | -113.8M | -460.2M |
| Income tax | 88.9M | 142.4M | 89.4M | 164.6M | 180.4M | -54.3M | 2.80M | -26.9M | -314.9M |
| Net income | -530.2M | 711.5M | 321.1M | 686.5M | 572.6M | 116.6M | 37.8M | -86.9M | -112.7M |
| Earnings per share, basic | -0.78 | 1.05 | 0.48 | 1.02 | 0.86 | 0.09 | -0.84 | -2.69 | -2.75 |
| Earnings per share, diluted | -0.78 | 1.04 | 0.47 | 1.01 | 0.85 | 0.09 | -0.84 | -2.69 | -2.75 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 365.4M | 261.9M | 262.9M | 372.9M | 301.7M | 286.6M | 186.7M | 184.7M | 188.5M |
| Receivables | 1.07B | 1.03B | 1.15B | 1.22B | 1.22B | 1.11B | 988.8M | 931.2M | |
| Inventory | 818.2M | 731.5M | 828.1M | 913.5M | 872.0M | 739.6M | 711.2M | 671.1M | |
| Current assets | 2.45B | 2.15B | 2.38B | 2.66B | 2.48B | 2.23B | 2.02B | 1.90B | |
| Property, plant and equipment | 766.8M | 708.1M | 737.5M | 727.0M | 705.5M | 549.9M | 557.0M | 598.6M | |
| Goodwill | 4.99B | 5.54B | 5.72B | 5.65B | 5.34B | 2.86B | 2.77B | 2.78B | 2.85B |
| Total assets | 11.8B | 12.1B | 13.0B | 13.5B | 13.9B | 9.91B | 9.77B | 9.91B | |
| Accounts payable | 741.7M | 662.8M | 625.9M | 758.2M | 755.1M | 678.9M | 560.2M | 557.4M | |
| Current liabilities | 1.38B | 2.01B | 1.48B | 1.66B | 1.45B | 1.24B | 1.07B | 1.10B | |
| Long-term debt | 3.92B | 3.23B | 5.28B | 5.92B | 6.98B | 4.87B | 5.02B | 6.78B | |
| Total debt | 3.95B | 4.06B | 5.54B | 6.29B | 7.02B | 4.89B | 5.12B | 6.92B | |
| Total liabilities | 6.23B | 6.16B | 7.72B | 8.61B | 9.70B | 7.23B | 7.31B | 9.10B | |
| Shareholders' equity | 5.57B | 5.96B | 5.25B | 4.86B | 4.20B | 2.67B | 2.46B | -3.05B | -2.62B |
| Shares outstanding | 682.0M | 680.8M | 676.6M | 674.3M | 609.7M | 580.1M | 572.8M | 132.8M | 580.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 623.8M | 840.8M | 870.0M | 843.6M | 953.6M | 929.8M | 354.0M | 200.5M | -167.5M |
| Capital spending | -128.8M | -148.8M | -146.4M | -133.4M | -111.1M | -61.6M | -51.6M | -37.7M | -25.2M |
| Free cash flow | 495.0M | 692.0M | 723.6M | 710.2M | 842.5M | 868.2M | 302.4M | 162.8M | -192.7M |
| Cash from investing | -130.5M | 438.9M | -143.7M | -109.6M | -4.12B | -59.1M | -42.1M | -23.2M | -6.68B |
| Cash from financing | -409.4M | -1.28B | -843.7M | -648.7M | 3.22B | -782.9M | -307.8M | -170.3M | 6.96B |
| Share buybacks | -75.1M | 0 | 0 | ||||||
| Change in cash | 103.6M | -23.0M | -109.2M | 69.8M | 37.9M | 99.9M | 1.60M | -800.0K | 122.5M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 3, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Oct 28, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 28, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 23, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 21, 2026 | Management or board change | SEC |
| 8-K · Current report | Sep 21, 2026 | Management or board change | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K/A · Current report, amended | Aug 27, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Jul 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 27, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 17, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 8-K · Current report | May 12, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | May 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 5, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Apr 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 29, 2026 | Results | SEC |
| CORRESP · Letter to the SEC | Apr 27, 2026 | Other filings | SEC |
| 8-K · Current report | Apr 23, 2026 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Apr 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Apr 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 1, 2026 | Management or board change | SEC |
| ARS · Annual report to shareholders | Mar 27, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 27, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 27, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 8-K/A · Current report, amended | Feb 25, 2026 | Management or board change | SEC |
| 8-K/A · Current report, amended | Feb 25, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 11, 2026 | Results | SEC |
| 10-K · Annual report | Feb 11, 2026 | Annual report | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 18, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 9, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 4, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Nov 17, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 12, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 10, 2025 | Management or board change | SEC |
| 144 · Notice of proposed sale | Nov 6, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 31, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 29, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 29, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 17, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 14, 2025 | Material contract | SEC |
| 8-K · Current report | Oct 14, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Oct 7, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 8-K · Current report | Oct 3, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Aug 13, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 1, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2025 | Results | SEC |
| 4 · Change in ownership | Jul 25, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 21, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 8-K · Current report | May 12, 2025 | Management or board change | SEC |
| 4 · Change in ownership | May 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 8-K · Current report | Apr 28, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | Apr 25, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 25, 2025 | Results | SEC |
| 3 · Initial statement of ownership | Apr 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Mar 28, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 28, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 28, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 27, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 27, 2025 | Other filings | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 26, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 26, 2025 | Other filings | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 10-K · Annual report | Feb 7, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 7, 2025 | Results | SEC |
| 8-K · Current report | Jan 8, 2025 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 6, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 6, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 6, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Oct 25, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 25, 2024 | Results | SEC |
| 4 · Change in ownership | Oct 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 5, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 26, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 16, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Aug 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Aug 7, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 1, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 31, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 30, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jul 26, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 26, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 26, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 26, 2024 | Results | SEC |
| 4 · Change in ownership | Jul 22, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Jul 10, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jul 3, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 25, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 21, 2024 | Management or board change | SEC |
| SD · Specialized disclosure | May 31, 2024 | ESG report | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2024 | Insider trade | SEC |
| 8-K · Current report | May 10, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Apr 26, 2024 | Quarterly report | SEC |
| 8-K · Current report | Apr 26, 2024 | Results | SEC |
This page holds 200 of 788 filings. Open Filings
Cap table
Built by 6ix from Avantor, Inc.’s releases · as of Oct 23, 2026
- Common shares
- 677,615,769
- Fully diluted
- 677,615,769
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 677,615,769 | Oct 23, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 23, 2026 | 677,615,769 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gregory T. Lucier Other companies: Maravai LifeSciences Holdings, Inc. (Director · Since at least Nov 19, 2020); Dentsply Sirona Inc. (Non-Executive Chairman of the Board · Since at least May 22, 2019); Berkeley Lights Inc (Director · Jul 16, 2020 – May 26, 2022 · Past); Catalent Inc (Director · May 9, 2019 – Dec 18, 2024 · Past); NuVasive Inc (Director · May 8, 2019 – May 18, 2021 · Past) | Director · Since at least Oct 3, 2025 |
| Rajiv Gupta Other companies: DuPont de Nemours, Inc. (Director · Jun 1, 2019 – May 27, 2020 · Past); Howmet Aerospace Inc. (Director · Nov 1, 2016 – May 16, 2019 · Past); Johnson Controls International plc (Director · Mar 5, 2016 – Sep 2, 2016 · Past); HP Inc. (Director · Dec 2, 2015 – May 5, 2016 · Past); Aptiv PLC (Director · Aug 26, 2015 – Apr 26, 2022 · Past) | Director · May 16, 2019 – Apr 1, 2022 · Past |
| Christi Shaw Other companies: Kyverna Therapeutics, Inc. (Executive Chairperson · Since at least Sep 16, 2024); Beam Therapeutics Inc. (Board Member · Since at least Dec 13, 2023); Eli Lilly and Company (SVP and Pres., Lilly Bio-Meds · Apr 3, 2017 – May 3, 2019 · Past) | Director · May 16, 2019 – May 11, 2023 · Past |
| Gregory L. Summe Other companies: NXP Semiconductors N.V. (Director · Since at least Jun 10, 2026); Wheels Up Experience Inc. (Director · Since at least Jun 9, 2026); GRAIL, Inc. (Director · Since at least Apr 15, 2026) | Director · Since at least May 7, 2026 |
| Jonathan M Peacock Other companies: Bellerophon Therapeutics Inc (Director · Feb 13, 2015 – Mar 31, 2021 · Past); Kite Pharma Inc (Director · Jun 19, 2014 – Oct 3, 2017 · Past); Amgen Inc. (EVP & CFO · Apr 25, 2013 – Oct 28, 2013 · Past) | Director · May 16, 2019 – May 8, 2025 · Past |
| Juan Andres Other companies: Lonza Group AG (Independent Member of the Board of Directors · Since at least May 8, 2026); Evelo Biosciences, Inc. (Director · Dec 4, 2019 – Jun 8, 2023 · Past); Moderna, Inc. (See remarks · Dec 7, 2018 – Dec 28, 2022 · Past) | Director · Sep 20, 2019 – May 8, 2025 · Past |
| Michael Severino Other companies: Sarepta Therapeutics, Inc. (Chief Executive Officer · Since at least Jul 27, 2026); Viatris Inc. (Director · Since at least May 5, 2025); AbbVie Inc. (Vice Chairman · Jun 2, 2014 – May 23, 2022 · Past) | Director · Since at least Apr 22, 2020 |
| Joseph R Massaro Other companies: Aptiv PLC (Vice Chair & President, EC · Since at least Mar 1, 2016); Delphi Technologies PLC (See Remarks, Director · Nov 15, 2017 – Nov 15, 2017 · Past) | Director · Since at least Nov 8, 2021 |
| Mala Murthy Other companies: TriNet Group, Inc. (Executive Vice President and Chief Financial Officer · Since at least Oct 29, 2025); Teladoc Health, Inc. (CHIEF FINANCIAL OFFICER · Since at least Jun 28, 2019) | Director · Since at least Oct 28, 2021 |
| Meghan Henson Other companies: Agilent Technologies, Inc. (Senior Vice President · Since at least Nov 18, 2025); Mama's Creations, Inc. (Director · Since at least Dec 19, 2022) | EVP, Chief HR Officer · Dec 31, 2020 – Feb 23, 2023 · Past |
All 37 people
| Person | Seat |
|---|---|
| Michael Wondrasch Other companies: Kimberly-Clark Corporation (Chief Consumer Growth Technology Officer · Since at least Nov 5, 2026); Kenvue Inc. (Chief Consumer Growth Technology Officer · Since at least Aug 7, 2025) | EVP & CIO · May 16, 2019 – Feb 20, 2023 · Past |
| Simon Dingemans Other companies: Vodafone Group Public Limited Company (Independent Non-Executive Director · Since at least May 12, 2026); WPP PLC (Non-Executive Director · Since at least Dec 18, 2025) | Director · Since at least Dec 18, 2025 |
| Andre V Moura Other companies: Bellerophon Therapeutics Inc (Director · Apr 28, 2016 – Sep 10, 2020 · Past) | Director · May 16, 2019 – May 16, 2019 · Past |
| Brent Jones Other companies: ESAB Corporation (Executive Vice President, Chief Financial Officer · Since at least May 7, 2026) | EVP, Chief Financial Officer · Since at least Aug 7, 2023 |
| Christophe Couturier Other companies: Tempest Therapeutics, Inc. (Chief Financial Officer · Sep 6, 2016 – Mar 2, 2017 · Past) | EVP, AMEA · Since at least May 16, 2019 |
| Louise Makin Other companies: Halma plc (Chair · Since at least Jul 24, 2025) | Director · Since at least Nov 4, 2024 |
| Steven W Eck Other companies: CSS Industries Inc (VP - Finance and Accounting · Jul 31, 2018 – Aug 6, 2018 · Past) | SVP & Chief Accounting Officer · Since at least May 23, 2019 |
| Todd Garner Other companies: CONMED Corporation (Executive Vice President & CFO · Since at least Jan 2, 2018) | Executive Vice President and Chief Financial Officer · Since Sep 21, 2026 |
| Allison Hosak | Investor Relations · Since at least Jan 12, 2026 |
| Benoit Gourdier | EVP, Bioscience & Medtech · Since at least Oct 2, 2023 |
| Brittany Hankamer | EVP, Chief HR Officer · Since at least Aug 14, 2026 |
| Chris Fidyk | Investor Relations · Since at least Oct 28, 2026 |
| Claudius Sokenu | EVP, Chief Legal & Compliance · Since at least Jul 24, 2026 |
| Corey Walker | President, VWR Dist. & Servs. · Since at least Jun 21, 2024 |
| Emmanuel Ligner | President and CEO, Director · Since at least Aug 18, 2025 |
| Frederic Vanderhaegen | EVP, Americas and Europe · May 16, 2019 – Aug 25, 2023 · Past |
| Gerard Brophy | EVP, Biopharma Production · May 16, 2019 – May 17, 2023 · Past |
| Gladys Wang | Vice President, Bioprocessing Commercial, Asia, Middle East & Africa · Since at least Dec 26, 2025 |
| John Carethers | Director · Jul 15, 2021 – May 8, 2025 · Past |
| Kitty Sahin | EVP, Strategy&Corp Development · Jul 18, 2023 – Jul 18, 2024 · Past |
| Lan Kang | Director · May 14, 2021 – May 8, 2025 · Past |
| Ludovic Brellier | Executive Vice President, Bioscience & Medtech Products · Since at least Apr 24, 2026 |
| Mary Blenn | Executive Vice President and Chief Operating Officer · Since at least Nov 10, 2025 |
| Mikey Santiago | Chief Information Officer · Since at least Oct 26, 2026 |
| Sanjeev Mehra | Director · Since at least Dec 4, 2025 |
| Swati Chhabra | Manager, Corporate Communications · Since at least Dec 26, 2025 |
| Tanya Foxe | EVP, Operations & Supply Chain · Sep 30, 2019 – Feb 21, 2020 · Past |
Log in to ask 6ix AI your own questions about Avantor, Inc.